Strong Revenue Growth
Waystar reported a 12% year-over-year revenue growth, reaching $269 million, with an adjusted EBITDA margin of 42%.
Acquisition of Iodine Software
Waystar completed the acquisition of Iodine Software, expanding the total addressable market by more than 15% and adding nearly 150 health systems to its client base.
AI-Powered Platform Innovations
Waystar introduced new AI-powered capabilities focusing on denial prevention, denial recovery, and patient financial engagement, leading to significant efficiency improvements.
Positive Client Feedback
Waystar reported a 93% confidence level from clients as a trusted partner and received two prestigious awards: Best Workplaces for Innovators in North America and Healthcare Company of the Year.
Financial Guidance Increase
Waystar raised its full-year revenue guidance to $1.085 billion to $1.093 billion and adjusted EBITDA guidance to $451 million to $455 million.